Literature DB >> 20838829

Characterization of the osteoblast-specific transmembrane protein IFITM5 and analysis of IFITM5-deficient mice.

Nobutaka Hanagata1, Xianglan Li, Hiromi Morita, Taro Takemura, Jie Li, Takashi Minowa.   

Abstract

Interferon-inducible transmembrane protein 5 (IFITM5) is an osteoblast-specific membrane protein whose expression peaks around the early mineralization stage during the osteoblast maturation process. To investigate IFITM5 function, we first sought to identify which proteins interact with IFITM5. Liquid chromatography mass spectrometry revealed that FK506-binding protein 11 (FKBP11) co-immunoprecipitated with IFITM5. FKBP11 is the only protein it was found to interact with in osteoblasts, while IFITM5 interacts with several proteins in fibroblasts. FKBPs are involved in protein folding and immunosuppressant binding, but we could not be sure that IFITM5 participated in these activities when bound to FKBP11. Thus, we generated Ifitm5-deficient mice and analyzed their skeletal phenotypes. The skeletons, especially the long bones, of homozygous mutants (Ifitm5(-/-)) were smaller than those of heterozygous mutants (Ifitm5(+/-)), although we did not observe any significant differences in bone morphometric parameters. The effect of Ifitm5 deficiency on bone formation was more significant in newborns than in young and adult mice, suggesting that Ifitm5 deficiency might have a greater effect on prenatal bone development. Overall, the effect of Ifitm5 deficiency on bone formation was less than we expected. We hypothesize that this may have resulted from a compensatory mechanism in Ifitm5-deficient mice.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20838829     DOI: 10.1007/s00774-010-0221-0

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  34 in total

1.  Extracellular bone acidic glycoprotein-75 defines condensed mesenchyme regions to be mineralized and localizes with bone sialoprotein during intramembranous bone formation.

Authors:  Jeff P Gorski; Aimin Wang; Dinah Lovitch; Douglas Law; Kimerly Powell; Ronald J Midura
Journal:  J Biol Chem       Date:  2004-03-05       Impact factor: 5.157

Review 2.  Structure-function relationships in the FK506-binding protein (FKBP) family of peptidylprolyl cis-trans isomerases.

Authors:  J E Kay
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

3.  The rat gene homologous to the human gene 9-27 is involved in the development of the mammary gland.

Authors:  I Zucchi; C Montagna; L Susani; P Vezzoni; R Dulbecco
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

4.  Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts.

Authors:  T Komori; H Yagi; S Nomura; A Yamaguchi; K Sasaki; K Deguchi; Y Shimizu; R T Bronson; Y H Gao; M Inada; M Sato; R Okamoto; Y Kitamura; S Yoshiki; T Kishimoto
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

5.  NFAT and Osterix cooperatively regulate bone formation.

Authors:  Takako Koga; Yuichi Matsui; Masataka Asagiri; Tatsuhiko Kodama; Benoit de Crombrugghe; Kazuhisa Nakashima; Hiroshi Takayanagi
Journal:  Nat Med       Date:  2005-07-24       Impact factor: 53.440

6.  The human FK506-binding proteins: characterization of human FKBP19.

Authors:  Stuart L Rulten; Ross A Kinloch; Hilda Tateossian; Colin Robinson; Lucy Gettins; John E Kay
Journal:  Mamm Genome       Date:  2006-04-04       Impact factor: 2.957

7.  Regulation of expression of mouse interferon-induced transmembrane protein like gene-3, Ifitm3 (mil-1, fragilis), in germ cells.

Authors:  Satomi S Tanaka; Go Nagamatsu; Yuko Tokitake; Miyuki Kasa; Patrick P L Tam; Yasuhisa Matsui
Journal:  Dev Dyn       Date:  2004-08       Impact factor: 3.780

8.  Bone acidic glycoprotein-75 delineates the extracellular sites of future bone sialoprotein accumulation and apatite nucleation in osteoblastic cultures.

Authors:  Ronald J Midura; Aimin Wang; Dinah Lovitch; Douglas Law; Kimerly Powell; Jeff P Gorski
Journal:  J Biol Chem       Date:  2004-03-05       Impact factor: 5.157

9.  The fragilis interferon-inducible gene family of transmembrane proteins is associated with germ cell specification in mice.

Authors:  U C Lange; M Saitou; P S Western; S C Barton; M A Surani
Journal:  BMC Dev Biol       Date:  2003-03-19       Impact factor: 1.978

10.  Bone sialoprotein plays a functional role in bone formation and osteoclastogenesis.

Authors:  Luc Malaval; Ndéyé Marième Wade-Guéye; Maya Boudiffa; Jia Fei; Ralph Zirngibl; Frieda Chen; Norbert Laroche; Jean-Paul Roux; Brigitte Burt-Pichat; François Duboeuf; Georges Boivin; Pierre Jurdic; Marie-Hélène Lafage-Proust; Joëlle Amédée; Laurence Vico; Janet Rossant; Jane E Aubin
Journal:  J Exp Med       Date:  2008-05-05       Impact factor: 14.307

View more
  54 in total

Review 1.  Bone biology: insights from osteogenesis imperfecta and related rare fragility syndromes.

Authors:  Roberta Besio; Chi-Wing Chow; Francesca Tonelli; Joan C Marini; Antonella Forlino
Journal:  FEBS J       Date:  2019-07-05       Impact factor: 5.542

Review 2.  IFITM5 mutations and osteogenesis imperfecta.

Authors:  Nobutaka Hanagata
Journal:  J Bone Miner Metab       Date:  2015-06-02       Impact factor: 2.626

3.  A transgenic mouse model of OI type V supports a neomorphic mechanism of the IFITM5 mutation.

Authors:  Caressa D Lietman; Ronit Marom; Elda Munivez; Terry K Bertin; Ming-Ming Jiang; Yuqing Chen; Brian Dawson; Mary Ann Weis; David Eyre; Brendan Lee
Journal:  J Bone Miner Res       Date:  2015-03       Impact factor: 6.741

4.  Effects of targeted modulation of miR-762 on expression of the IFITM5 gene in Saos-2 cells.

Authors:  Xinkai Mo; Yanqin Lu; Jinxiang Han
Journal:  Intractable Rare Dis Res       Date:  2014-02

Review 5.  Regulation of the trafficking and antiviral activity of IFITM3 by post-translational modifications.

Authors:  Nicholas M Chesarino; Temet M McMichael; Jacob S Yount
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

6.  PHENOTYPIC VARIABILITY IN INDIVIDUALS WITH TYPE V OSTEOGENESIS IMPERFECTA WITH IDENTICAL IFITM5 MUTATIONS.

Authors:  Jamie Fitzgerald; Paul Holden; Hollis Wright; Beth Wilmot; Abigail Hata; Robert D Steiner; Don Basel
Journal:  J Rare Disord       Date:  2013-12

7.  Type V OI primary osteoblasts display increased mineralization despite decreased COL1A1 expression.

Authors:  Adi Reich; Alison S Bae; Aileen M Barnes; Wayne A Cabral; Aleksander Hinek; Jennifer Stimec; Suvimol C Hill; David Chitayat; Joan C Marini
Journal:  J Clin Endocrinol Metab       Date:  2014-11-11       Impact factor: 5.958

8.  Regulation of the bone-restricted IFITM-like (Bril) gene transcription by Sp and Gli family members and CpG methylation.

Authors:  Bahar Kasaai; Marie-Hélène Gaumond; Pierre Moffatt
Journal:  J Biol Chem       Date:  2013-03-24       Impact factor: 5.157

9.  Osteogenesis imperfecta without features of type V caused by a mutation in the IFITM5 gene.

Authors:  Monica Grover; Philippe M Campeau; Caressa Dee Lietman; James T Lu; Richard A Gibbs; Alan E Schlesinger; Brendan H Lee
Journal:  J Bone Miner Res       Date:  2013-11       Impact factor: 6.741

Review 10.  New genes in bone development: what's new in osteogenesis imperfecta.

Authors:  Joan C Marini; Angela R Blissett
Journal:  J Clin Endocrinol Metab       Date:  2013-06-14       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.